Top View
- Engineering Opportunities in Cancer Immunotherapy Laura Jeanbarta,B and Melody A
- Project Final Report
- Neoepiscope Improves Neoepitope Prediction with Multi-Variant Phasing
- The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer
- RNA Vaccines: an Introduction October 2018 Laura Blackburn
- Conference Program and Schedule
- Innovative Immunoinformatic Approaches for Mutanome-Directed Cancer Immunotherapy Leonard Moise1,2, Guilhem Richard1, Frances Terry1, William Martin1, Anne S
- Actively Personalized Cancer Vaccines Œ the Step Into Clinical Application
- NLRC5, a Promising New Entry in Tumor Immunology Sonia T
- Pioneering Individualized Cancer Therapies
- Hinz – Peptides-Cell Therapy
- Clinical and Immunological Effects of Mrna Vaccines in Malignant Diseases Annkristin Heine, Stefan Juranek and Peter Brossart*
- Exploiting the Mutanome for Tumor Vaccination
- Mrna Vaccines — a New Era in Vaccinology
- Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health
- Towards Personalized, Tumour-Specific, Therapeutic Vaccines for Cancer
- High-Value T Cell Epitope Selection for Mutanome-Directed Cancer Immunotherapy Using an Innovative Cancer Neo-Epitope Classification System
- Cancer Immunogenomic Approach to Neoantigen Discovery in A
- Mining the Mutanome: Developing Highly Personalized
- The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
- Open Full Page
- Mutanome Draws Genentech Deal
- Translation of Genomics-Guided RNA-Based Personalised Cancer Vaccines: Towards the Bedside